In vivo knockdown of Eg5 was also effective in UG87 glioblastoma and MDA-MB-231 breast cancer [28], ovarian cancer and melanoma [31] and EPP85 pancreatic tumour xenograft models [26]. Here, KIF11 is linked to breast cancer.